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Abstract Artificial insemination (AI) is an assisted
reproductive technique that is implemented success-
fully in humans as a fertility treatment, performed
extensively for commercial breeding of livestock, and
is also successful in laboratory rodents. AI in the
mouse may be especially useful for breeding of
transgenic or mutant mice with fertility problems,
expansion of mouse colonies, and as an alternative to
in vitro fertilization. Nonsurgical AI techniques for the
mouse have been described previously but are not
often implemented due to technical difficulties. Here
we compare various protocols for preparation of CD1
recipients prior to AI for naı¨ve (in estrus), ovulation-
induced, and superovulated females. Timing of hor-
mone administration relative to sperm delivery is also
compared. An improved protocol for nonsurgical AI in
mice is described, which incorporates a convenient
hormone administration schedule for female recipi-
ents and rapid, non-stressful sperm transfer without
the need for anesthesia or analgesia.
Keywords Artificial insemination  Nonsurgical 
NSET device  In vitro fertilization  Sperm 
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Introduction
Artificial insemination (AI) is used to assist in
reproduction by directly delivering motile sperm to
the female reproductive tract. Artificial insemination
in mice can be useful as an alternative to breeding for
strains which are not easily bred due to physical or
behavioral issues. The techniques of AI and in vitro
fertilization (IVF) can both be used to generate viable
embryos. Development after AI simply continues in
the recipient female, while embryos generated from
IVF must be transferred to a pseudopregnant recipient.
AI or IVF can be used to generate embryos after
cryopreservation of sperm, making them useful for
cryorecovery of mouse strains. IVF requires collection
of a large number of oocytes, fertilization is performed
in vitro, and embryos are then transferred into a
suitable recipient host for development. The process
can be time consuming, technically challenging, and
the resources expensive. AI is a convenient alternative
to IVF for some applications. In theory, the AI
technique is quite simple; sperm are directly added to
the reproductive tract of the recipient female and all
further development occurs in vivo. Historically,
however, procedures for AI in mice have had variable
rates of success, tend to be complicated, and as a result
are underutilized.
AI can be performed either surgically or nonsurgi-
cally. The surgical procedure has the benefit of using a
small volume of sperm injected directly into the
oviduct (Nakagata 1992; De Repentigny and Kothary
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1996) or bursa (Sato and Kimura 2001; Sato et al.
2002) to produce viable embryos. Surgical AI using
previously cryopreserved sperm has also been used to
generate live pups (Nakagata 1992). However, this
procedure requires surgical training and use of anes-
thesia and analgesia. The surgical procedure requires
opening of the abdominal cavity to reach the female
reproductive tract, an invasive procedure requiring
pain relief and post-operative supportive care.
The use of various nonsurgical methods has also
been previously reported. AI has been performed with
varying degrees of success in laboratory mice (Mus
musculus) to produce implanted fetuses (Dziuk and
Runner 1960; Leckie et al. 1973). Dziuk and Runner
(1960) describe a transcervical technique using a blunt
needle and a glass speculum to transfer sperm to mice,
which then receive a daily progesterone administra-
tion. Leckie et al. (1973) describe a procedure to
transfer sperm transcervically with a blunt needle,
with the use of an artificial penis and a vaginal tampon
(as an alternative to pairing with a vasectomized male
to induce a pseudopregnant state) to increase the
efficiency of embryo implantation. More recently,
nonsurgical transcervical AI has been performed
under general anesthesia for production of embryos
in superovulated deer mice (Peromyscus maniculatus)
(Veres et al. 2012). While techniques for assisted
reproduction in Peromyscus have generally lagged
behind techniques available for Mus, attempts are
being made to refine methods for embryo recovery and
in vitro culture (Veres et al. 2012). To this end, a
nonsurgical AI technique introducing sperm into the
vagina without anesthesia has also been described for
Peromyscus for use with females in estrus or with
superovulated females (Behringer et al. 2014; Duselis
and Vrana 2007). However, data from the nonsurgical
AI procedures regarding the production of live pups is
not available.
The laboratory mouse community is in need of a
simple user-friendly method for AI, one that also
creates an ethical standard for treatment to mice. To
develop this protocol, we first examined some variable
aspects of the previously described surgical and
nonsurgical AI techniques available for Mus. (1)
Hormone administration can be used to induce timed
estrus and ovulation to generate oocytes for fertiliza-
tion. However, superovulation has been shown to have
adverse effects on embryonic and fetal development
(Beaumont and Smith 1975; Ertzeid and Storeng
1992; Van der Auwera and D’Hooghe 2001; Van der
Auwera et al. 1999). (2) Timing of hormone admin-
istration relative to sperm delivery needs to be
considered. Given a natural estrus situation, ovulation
and fertilization is thought to occur around midnight,
during the dark cycle (Behringer et al. 2014). Oocytes
generated after hormone induced ovulation are most
efficiently fertilized from surgical AI 7–12 h after
administration of hCG, corresponding to timing of
ovulation (Sato et al. 2004). This timing of ovulation
and fertilization is rather inconvenient for routine use
of AI. (3) Induction of pseudopregnancy in the
recipient before (Nakagata 1992; De Repentigny and
Kothary 1996; Sato and Kimura 2001; Sato et al.
2002), during (Leckie et al. 1973), or after (this study)
insemination is required for fetal development. These
three variables have made use of techniques for AI in
mice problematic.
While surgical and nonsurgical techniques for AI
have been developed for use in mice, adoption of these
techniques for routine use has not occurred. Therefore,
our goal was to develop a simple and convenient
protocol for AI in mice that would result in the birth of
healthy pups. To that end, we compared various
protocols for preparation of female recipients prior to
AI; naı¨ve (in estrus), ovulation induced, and super-
ovulated females. Sperm transfer was performed with
the NSET device, typically used for nonsurgical
embryo transfer in mice (Green et al. 2009; Bin Ali
et al. 2014), because it has been shown to be less
stressful to mice than a comparable surgical procedure
(Steele et al. 2013). Timing of hormone administration
relative to sperm delivery was also compared. As a
result, an improved protocol for nonsurgical AI inmice
is described. This protocol incorporates a convenient
hormone administration schedule for female recipients
and a rapid, non-stressful sperm transfer, without the
need for anesthesia or analgesia. The protocol can be
used to produce large litters of healthy pups.
Methods
Animals
All animal research was approved by the ParaTechs
Institutional Animal Care and Use Committee and
conducted under the standards dictated by the Office
of Laboratory Animal Welfare, National Institutes of
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Health, Public Health Service, United States Depart-
ment of Health and Human Services. All mice were
obtained from Charles River Laboratories (Wilming-
ton, MA, USA). Vasectomized male CD1 mice
([2 months old) were used to induce pseudopreg-
nancy. Female CD1 mice between 2 and 5 months old
were used as sperm recipients. Male C3H mice
([2 months old) with proven fertility were used as
sperm donors. The vivarium was maintained at
20–22 C with an average relative humidity of
35–50 % under a 12:12 h light:dark (light from 8 am
to 8 pm) cycle. Mice were housed in standardized
ventilated microisolation caging (Innovive, San
Diego, CA, USA). Mice had access to Teklad Global
19 % protein extruded rodent diet #2919 (Harlan
Laboratories, Madison, WI, USA) and bottled sterile
water (Innovive) ad libitum.
Sperm isolation and preparation
Human tubal fluid medium (HTF) (Irvine Scientific,
Santa Ana, CA, USA, Cat #90126) was prepared by
adding 4 mg/ml bovine serum albumin (BSA) (Sigma-
Aldrich, St. Louis, MO, USA, Cat #A3311), and filter
sterilizing. The HTF media was equilibrated prior to
use for at least 30 min at 37 C in the presence of 5 %
CO2. Fresh sperm was collected from the cauda
epididymis and vas deferens of C3H males. The sperm
was capacitated in 500 ll freshly prepared HTF media
under embryo culture grade mineral oil (Sigma-
Aldrich, Cat #M8410) at 37 C in the presence of
5 % CO2 for 45 min.
Hormone administration
Pregnant mare serum gonadotropin (PMSG) and
human chorionic gonadotropin (hCG, Cat#
AFP8456A) were obtained from the National Hor-
mone and Peptide Program, National Institute of
Diabetes and Digestive and Kidney Diseases, (Tor-
rance, CA, USA) and diluted in sterile phosphate
buffered saline (PBS) (Butler-Schein, Dublin, OH,
USA, Cat #002477) to 1000 IU/ml, and stored at
-80 Cuntil use. Female CD1mice for this studywere
either naı¨ve (chosen by outward appearance to be in
estrus) or were injected with hormones for induction of
estrus or superovulation. For naı¨ve females, estrus
cycle indicators were observed as previously described
(Behringer et al. 2014). Superovulated females were
prepared by intraperitoneal (i.p.) injection with 5 IU
PMSG and hCG administered*47 h apart at various
time schedules relative to the vivarium light–dark
cycle. To induce a more natural ovulation condition in
CD1 females, the hormones were reduced to 1 IU per
i.p. injection.
Artificial insemination
After optimization of the procedure, a total of 40 ll of
fresh sperm was transferred to the uterine horns of
female CD1mice. The transfer was performed without
the use of anesthesia or analgesia and took\1 min per
mouse. Sperm transfer was carried out using a
commercially available device originally developed
for nonsurgical embryo transfer in mice, the NSETTM
device (ParaTechs, Lexington, KY, USA). The NSET
device, a tapered Teflon catheter connected to a
specially designed hub, was attached to a Rainin P20
pipette (Mettler-Toledo, Columbus, OH, USA). The
device was loaded with 20 ll sperm from the edge of
the sperm sample, avoiding clumps. The un-anes-
thetized recipient female was placed on a wire bar
cage top and allowed to grasp the surface with its
forefeet. The mouse was held at the base of the tail
using a thumb and forefinger, and the rear angled
slightly upward, while lightly pressing the base of the
hind legs with two fingers from the same hand. The
holding technique has been described previously for
nonsurgical embryo transfer (Green et al. 2009) and a
video of the procedure is available (www.paratechs.
com/nset/). Either the small or large speculum inclu-
ded with the device was used to hold open the vagina.
If the larger diameter speculum was used, the cervix
could be visually located with the aid of a direct light
source. The NSET tip was inserted through the cervix
and into the uterus. Once the NSET hub contacted the
speculum, the sperm was expelled by pressing the
pipette plunger to the first stop. The procedure was
then repeated to deliver a total sperm volume of 40 ll.
The speculum was removed, and the mouse was
immediately paired with a vasectomized male over-
night. No post-procedure monitoring was required.
Results
Initial attempts to perform AI using the NSET device
for sperm transfer followed a previously described
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protocol for nonsurgical insemination (Nagy et al.
2003) with the exception that sperm transfer occurred
at the time of hCG injection (instead of 13.5 h after
hCG injection). The females were injected i.p. with 0.5
or 1.0 IU PMSG at 1 pm 2 days prior to sperm transfer
and 0.5 or 1.0 IU hCG at noon the day of sperm
transfer. The NSET device was used to transfer
15–20 ll sperm just prior to hCG injection. The
recipient was immediately housed overnight with a
vasectomized male to mate, simulating normal breed-
ing behavior. However, no implantation sites were
observed (N = 17) and no pups were delivered
(N = 13) following these initial pilot studies.
To determine if fertilization of oocytes could occur
with this method, the protocol was modified and the
female recipients were injected with 5 IU of each
hormone to induce ovulation as before. After sperm
transfer and pairing overnight with a vasectomized
male, female recipients were euthanized and oviducts
were flushed with M2 medium. All AI procedures
resulted in viable embryos, with an average of 9.7
blastocysts developed after in vitro culture from an
average of 30.3 oocytes per ovulation (N = 20).
However, using this same protocol for insemination,
only three AI procedures resulted in implanted
embryos (N = 21). These results indicated that the
sperm transfer was successful in that oocytes were
fertilized and viable embryos were being produced.
However, implantation of embryos in the uterine horns
was inefficient.
Since the oocytes were being fertilized but implan-
tation was restricted, it was thought that the amount of
hormones administered for ovulation and/or the timing
of administration needed to be altered. In confirmation,
the first successful demonstration that the NSET device
could be used forAI to produce live pupswas performed
using an alternate injection schedule (A. Harman,
personal communication, Children’s Hospital of
Philadelphia, PA, USA). 5 IU PMSG was injected at
8:30 pm 3 days prior to sperm transfer and 5 IU hCG at
8:00 pm 1 day prior to sperm transfer. Sperm volume
was increased to 40 ll; transferring this volume
required two transcervical sperm deliveries per female.
The AI procedure produced a litter of pups in a strain of
obese mice (that was unable to copulate). In our hands,
this protocol resulted in a pregnancy rate of 36 %
(N = 19) (Table 1; Trial 9) in female CD1 mice, with
litter sizes ranging from 2 to 9 pups, and an average of
4.5 pups per litter. However, pup mortality was high
(57 %) with only 13 of 32 pups surviving to weaning.
To increase pregnancy rates and to find a more
convenient work schedule, other hormone injection
and sperm transfer times were tested using PMSG and
hCG at concentrations of 5 IU. No increase in preg-
nancy rate was achieved after administration of 5 IU of
hormones prior to AI, although an increase in litter size
(10 pups on average) and an improvement in survival
rate (to 100 %) were observed when the injection
schedule was begun earlier in the day (Table 1; Trial 8).
With the aim of potentially increasing embryo
implantation and improving the health of the pups
resulting from the AI protocol, a decrease was made in
the amount of hormones delivered to the female prior
to sperm transfer. First, females in estrus were selected
as AI recipients (N = 20). No hormones were admin-
istered to induce ovulation. AI was performed at
5:00 pm or at 8:00 pm (Table 1; Trials 1 and 2) before
females were paired with vasectomized males over-
night. No pups were obtained. Control matings with
stud males confirmed that the females were receptive.
The pregnancy rate for control matings was 50 % with
an average litter size of 12 pups (N = 6). Next, female
AI recipients were given low levels of hormones to
induce a more natural ovulation condition; PMSG and
hCGwere reduced to 1 IU per i.p. injection, given 47 h
apart. With the administration of a lower hormone
dose, a trend was observed in improvement in preg-
nancy rate and pup health. The protocol with the
highest pregnancy rate (Trial 14) followed a conve-
nient time schedule for hormone injections and AI.
1 IU of PMSG was administered at 5:30 pm 3 days
prior to sperm transfer and 1 IU of hCG was admin-
istered at 5:00 pm 1 day prior to sperm transfer to
ovulate AI recipients. The next morning, sperm was
collected at 8:00 am, capacitated for 1 h, and 40 ll
delivered at 9:00 am transcervically to AI recipients.
Recipients were immediately paired with vasec-
tomized males overnight. Full term pregnancy rates
with fresh sperm reached 50 % (N = 20) (Table 1;
Trial 14). Litter size averaged 5.0 pups with all pups
surviving to weaning.
Discussion
A protocol refinement for nonsurgical AI in mice is
described, which incorporates a convenient hormone
administration schedule for female recipients and
778 Transgenic Res (2015) 24:775–781
123
rapid, non-stressful sperm transfer without the need
for anesthesia or analgesia. Sperm transfer was
performed using the NSET device for mice, originally
designed for nonsurgical transfer of embryos into the
uterine horns of pseudopregnant female mice. The
device consists of a flexible Teflon catheter that is able
to pass the cervix and deposit embryos or sperm into
the uterine horn. Utilization of the device for embryo
transfer is considered a refinement (Steele et al. 2013)
according to Russell and Burch’s ‘3Rs’ of animal
research (Russell and Burch 1959) defining alternative
procedures which either replace animals, reduce the
number of animals used, or refine methodologies to
minimize pain or distress. In the case of AI, use of the
NSET device provides a convenient 3Rs refinement to
a surgical procedure (Nakagata 1992; De Repentigny
and Kothary 1996; Sato and Kimura 2001) and an
alternative to a nonsurgical transcervical procedure
using a blunt needle and glass speculum (Dziuk and
Runner 1960), or a nonsurgical procedure requiring an
artificial penis and vaginal tampon (Leckie et al. 1973;
Takeshima and Toyoda 1977).
Table 1 AI procedures
Trial Hormone
delivery






1 None AI 5:00 pm 0 % NA NA
2 None AI 8:00 pm 0 % NA NA
3 5 IU PMSG 8:30 am hCG 8:00 am
AI 12:00 pm
0 % NA NA





5 5 IU PMSG 8:30 am hCG 8:00 am
AI 10:00 pm
0 % NA NA
6 5 IU PMSG 12:00 pm hCG 11:00 am
AI 11:00 am
0 % NA NA
7 5 IU PMSG 12:00 pm hCG 11:00 am AI 11:00 am 10 % 1.0
(1)
0 %
8 5 IU PMSG 5:30 pm hCG 5:00 pm AI 9:00 am 30 % 10.0
(7–13)
100 %
9 5 IU PMSG 8:30 pm hCG 8:00 pm AI 9:30 am 36 % 4.5
(2–9)
43 %
10 5 IU PMSG 6:30 pm hCG 6:00 pm
AI 5:30 pm
0 % NA NA










13 1 IU PMSG 8:30 pm hCG 8:00 pm AI 9:30 am 10 % 1.0
(1)
100 %
14 1 IU PMSG 5:30 pm hCG 5:00 pm AI 9:00 am 50 % 5.0
(1–12)
100 %
Hormone concentrations, hormone administration, and sperm delivery schedules are shown for individual AI trials. Pregnancy rates,
average litter size, the range of litter size, and the survival rate of pups to weaning age (21 days) are indicated. Sperm was delivered
using the NSET device for mice without anesthesia. Analysis of data by Fisher’s exact test shows that a 13–16 h time interval
between the hCG hormone injection and AI has a significant positive effect on pregnancy rates (p\ 0.05) relative to other conditions
tested. By the same test, administration of a hormone concentration of 1 IU has a significant positive effect on pup survival rate
(p\ 0.05) over 5 IU. No significant effect of hormone concentration on litter size or pregnancy rate is seen. Significance cannot be
determined between individual trials due to insufficient sample size
Transgenic Res (2015) 24:775–781 779
123
Nonsurgical AI is an assisted reproduction tech-
nique that has applications as a fertility treatment in
humans and for commercial breeding of livestock.
However, AI also has applications for use in labora-
tory mice. AI can be used for rapid expansion of
mouse colonies as well as for generating age-matched
cohorts for studies. Therefore, the use of AI may
reduce the need for large in-house breeding colonies to
provide mice for research projects. The ability to
rapidly expand colonies on-site could reduce the cost
of maintaining large breeding colonies. AI may be
especially useful for breeding of transgenic or mutant
mice with fertility problems and as an alternative to
in vitro fertilization. Additionally, sperm can be
shipped globally either cold (Takeo et al. 2012) or
cryopreserved using one of two efficient protocols
(Behringer et al. 2014), reducing the need to ship live
animals. Nonsurgical AI could provide a means to
rapidly recover a strain after shipment of sperm.
Additionally, use of this nonsurgical AI protocol has
potential to be coupled with thawed cryopreserved
sperm. As reviewed in Takeo and Nakagata (2010),
recent advances in cryopreservation of mouse strains
have increased viability of thawed sperm. Therefore,
transfer of thawed spermwith the NSET device has the
potential to provide an alternative to IVF for strain
cryorecovery.
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